12-120510130-G-C
Variant summary
Our verdict is Benign. Variant got -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBA1
The NM_032314.4(COQ5):c.575-7C>G variant causes a splice region, splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00556 in 1,606,548 control chromosomes in the GnomAD database, including 435 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_032314.4 splice_region, splice_polypyrimidine_tract, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
COQ5 | NM_032314.4 | c.575-7C>G | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | ENST00000288532.11 | NP_115690.3 | |||
COQ5 | XM_006719639.3 | c.332-7C>G | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | XP_006719702.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
COQ5 | ENST00000288532.11 | c.575-7C>G | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | 1 | NM_032314.4 | ENSP00000288532 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0288 AC: 4371AN: 152030Hom.: 218 Cov.: 31
GnomAD3 exomes AF: 0.00794 AC: 1996AN: 251410Hom.: 99 AF XY: 0.00569 AC XY: 773AN XY: 135896
GnomAD4 exome AF: 0.00313 AC: 4556AN: 1454400Hom.: 216 Cov.: 29 AF XY: 0.00265 AC XY: 1921AN XY: 724064
GnomAD4 genome AF: 0.0288 AC: 4384AN: 152148Hom.: 219 Cov.: 31 AF XY: 0.0274 AC XY: 2039AN XY: 74382
ClinVar
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
COQ5-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Dec 18, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at